Email us connect@hepdconnect.org
Welcome to Hepatitis Delta Connect!
A dedicated program of the Hepatitis B Foundation to increase awareness about hepatitis delta, a serious virus that coinfects hepatitis B patients, promote screening and testing, and provide information and support for those affected.
Clinical Trial Finder - Find A Clinical Trial Near You!
We've educated 13,000 people in 111 countries!
News & Updates
September Blog Post: New Hepatitis Delta Treatment Approved by European Commission
May Blog Post: Does Hepatitis Delta Increase My Risk for Liver Cancer?
View our recent webinar, Hepatitis Delta Treatment Endpoints: How Do We Measure Success in the Era of Emerging Therapies recording here.
Phase 3 clinical trials are now open for hepatitis delta, click here for more information.
9/17/20: Hepcludex Launched in Germany, France, and Austria
8/31/20: End of Treatment Results Presented for Lambda-Interferon + Lonafarnib Combination Phase 2 Study
8/5/20 Hepcludex approved by European Commission
6/2/20 MYR Pharmaceuticals receives positive opinion from EMA for Hepcludex for the treatment of chronic hepatitis delta
4/2/20 Coronavirus pandemic issues delay key Eiger's D-LIVR study
2/1/20 The effect of twelve weeks of treatment with ezetimibe on HDV RNA level in patients with chronic hepatitis D
Get Connected
